iTonic Holdings Ltd
iTonic Holdings Ltd is a U.S.-listed healthcare solutions company organized around Beijing Feitian Zhaoye Technology Co., Ltd., its wholly owned operating subsidiary in Beijing, China. The company develops treatment planning systems and related products and services for brachytherapy, a targeted radiation therapy used in cancer treatment.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueSoftware and systems used to plan brachytherapy procedures and treatment delivery.
Products used alongside brachytherapy treatment planning and execution.
Implementation, support, and related services for customers using the company’s systems.
Products
Reported · share of revenue- Sales of FTTPS69.4 %
- Sales of Medical Auxiliary Supplies30.6 %
Source: 20-F/A FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells to healthcare providers involved in cancer treatment, especially institutions that perform brachytherapy planning and delivery. Its buyers need specialized planning tools to support safe, targeted radiation therapy workflows and to standardize treatment across tumor applications.
Buy treatment planning systems for brachytherapy procedures and clinical workflow support.
Use the company’s planning tools to support targeted cancer treatment delivery.
May purchase related products and services that support deployment and use of the systems.
Strategy
The company’s stated direction is to build around brachytherapy treatment planning and expand the use of its products across multiple malignant tumor applications. Its strategy appears centered on leveraging the installed clinical workflow around its planning system while broadening market acceptance for related offerings.
Wider adoption increases the addressable base for the company’s core system.
Related products and services can deepen customer relationships and usage.
As a U.S.-listed foreign issuer, market access supports operating flexibility.
Geography
iTonic is legally domiciled in the United States and trades on Nasdaq, but its operating subsidiary and principal business base are in Beijing, China. The reports identify Beijing as the company’s operational center, which makes the business exposed to China-based regulatory, commercial, and operating conditions. The dual U.S.-listing and China operating footprint also shape how the company accesses capital and serves customers.
Risks
The company faces clinical-adoption risk because its products address a specialized cancer-treatment workflow that must gain acceptance from hospitals and physicians. It also carries U.S.-listed foreign issuer risk, including Nasdaq compliance, cross-border operating exposure, and the need to maintain access to capital while conducting business through a China-based subsidiary.
- Nasdaq minimum bid price complianceImpact: HighLikelihood: High
Failure to regain compliance can trigger delisting proceedings and reduce market access.
Exposure: Class A ordinary shares
- Clinical adoption of brachytherapy planning systemsImpact: HighLikelihood: Medium
Demand depends on healthcare providers adopting a specialized treatment workflow.
Exposure: Treatment planning system sales
- China operating and regulatory exposureImpact: MediumLikelihood: Medium
Operations are centered in Beijing through a Chinese subsidiary and may be affected by local rules.
Exposure: Beijing subsidiary and customer base
- Foreign issuer capital-market riskImpact: MediumLikelihood: Medium
The company depends on public-market access for funding and investor visibility.
Exposure: Nasdaq-listed structure
Accounting
Judgemental itemsProducts and related services may be delivered at different times, affecting reported revenue timing.
Impact: Bundled contracts can shift revenue between periods
Healthcare customer collections may require judgment over recoverability.
Impact: Could affect bad debt expense and net assets
Specialized technology businesses may need impairment testing if usage or demand weakens.
Impact: Can create non-cash charges if carrying values exceed recoverable amounts
Similar listed companies
Publicly listed companies with a comparable business focus.
Vivos Inc
RDGL · Surgical & Medical Instruments & Apparatus
Burning Rock Biotech Ltd
BNR · Services-Medical Laboratories
Burning Rock Biotech Ltd is a precision oncology company focused on applying next-generation sequencing to cancer care.
NeOnc Technologies Holdings, Inc
NTHI · Pharmaceutical Preparations
Zhongchao Inc.
ZCMD · Services-Educational Services
Wetouch Technology Inc.
WETH · Computer Peripheral Equipment, NEC
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Last updated: 28/09/2026